Korro Bio Files 8-K
Ticker: KRRO · Form: 8-K · Filed: Nov 21, 2024 · CIK: 1703647
| Field | Detail |
|---|---|
| Company | Korro Bio, Inc. (KRRO) |
| Form Type | 8-K |
| Filed Date | Nov 21, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, corporate-events, financial-reporting
TL;DR
Korro Bio filed an 8-K on Nov 21, 2024. Standard reporting.
AI Summary
Korro Bio, Inc. filed an 8-K on November 21, 2024, to report other events and financial statements. The company, formerly known as Frequency Therapeutics, Inc. until April 12, 2017, is incorporated in Delaware and headquartered in Cambridge, MA.
Why It Matters
This filing serves as an official notification of significant corporate events and financial reporting for Korro Bio, Inc., providing transparency to investors and the market.
Risk Assessment
Risk Level: low — This is a routine filing for corporate events and financial statements, not indicating any immediate material adverse changes.
Key Players & Entities
- Korro Bio, Inc. (company) — Registrant
- November 21, 2024 (date) — Date of Report
- Frequency Therapeutics, Inc. (company) — Former Company Name
- April 12, 2017 (date) — Date of Name Change
- Delaware (jurisdiction) — State of Incorporation
- Cambridge, MA (location) — Business Address
- 60 First Street, 2nd floor, Suite 250 (address) — Principal Executive Offices
- (617) 468-1999 (phone_number) — Registrant's telephone number
FAQ
What is the primary purpose of this 8-K filing for Korro Bio, Inc.?
The primary purpose of this 8-K filing is to report 'Other Events' and 'Financial Statements and Exhibits' as of November 21, 2024.
When was Korro Bio, Inc. formerly known by another name?
Korro Bio, Inc. was formerly known as Frequency Therapeutics, Inc. until April 12, 2017.
Where is Korro Bio, Inc. headquartered?
Korro Bio, Inc. is headquartered in Cambridge, MA, with its principal executive offices located at 60 First Street, 2nd floor, Suite 250.
What is the state of incorporation for Korro Bio, Inc.?
Korro Bio, Inc. is incorporated in Delaware.
What is the telephone number listed for Korro Bio, Inc.?
The telephone number listed for Korro Bio, Inc. is (617) 468-1999.
Filing Stats: 467 words · 2 min read · ~2 pages · Grade level 10.8 · Accepted 2024-11-21 07:35:22
Key Financial Figures
- $0.001 — ch registered Common stock, par value $0.001 per share KRRO The Nasdaq Capital M
Filing Documents
- krro-20241121.htm (8-K) — 47KB
- krro-ex99_1.htm (EX-99.1) — 24KB
- 0000950170-24-129488.txt ( ) — 228KB
- krro-20241121.xsd (EX-101.SCH) — 53KB
- krro-20241121_htm.xml (XML) — 5KB
01. Other Events
Item 8.01. Other Events. On November 21, 2024, Korro Bio, Inc. issued a press release announcing that it has received approval from the Australian Bellberry Human Research Ethics Committee and Clinical Trial Notification clearance from the Australian Therapeutic Goods Administration to initiate a first-in-human Phase 1/2a clinical study of KRRO-110 for Alpha-1 Antitrypsin Deficiency. A copy of the press release is filed as Exhibit 99.1 to this current report on Form 8-K and is incorporated herein by reference.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press release of Korro Bio, Inc., dated November 21, 2024 104 Cover Page Interactive Data File (Embedded within the Inline XBRL Document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. KORRO BIO, INC. Date: November 21, 2024 By: /s/ Ram Aiyar Name: Ram Aiyar Title: President and Chief Executive Officer